• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因及其编码的α1-抗胰蛋白酶蛋白在非小细胞肺癌中的临床意义

Clinical Significance of Gene and Its Encoded Alpha1-antitrypsin Protein in NSCLC.

作者信息

Ercetin Evrim, Richtmann Sarah, Delgado Beatriz Martinez, Gomez-Mariano Gema, Wrenger Sabine, Korenbaum Elena, Liu Bin, DeLuca David, Kühnel Mark P, Jonigk Danny, Yuskaeva Kadriya, Warth Arne, Muley Thomas, Winter Hauke, Meister Michael, Welte Tobias, Janciauskiene Sabina, Schneider Marc A

机构信息

Department of Respiratory Medicine, Hannover Medical School, 30625 Hannover, Germany.

Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), 30625 Hannover, Germany.

出版信息

Cancers (Basel). 2019 Sep 4;11(9):1306. doi: 10.3390/cancers11091306.

DOI:10.3390/cancers11091306
PMID:31487965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6770941/
Abstract

High expression of gene encoding acute phase protein, alpha1-antitrypsin (AAT), is associated with various tumors. We sought to examine the significance of and AAT protein in non-small-cell lung cancer (NSCLC) patients and NSCLC cell lines. Tumor and adjacent non-tumor lung tissues and serum samples from 351 NSCLC patients were analyzed for expression and AAT protein levels. We also studied the impact of expression and AAT protein on H1975 and H661 cell behavior, . Lower expression in tumor but higher in adjacent non-tumor lung tissues ( = 351, = 0.016) as well as higher serum levels of AAT protein ( = 170, = 0.033) were associated with worse survival rates. Specifically, in NSCLC stage III patients, higher blood AAT levels (>2.66 mg/mL) correlated with a poor survival ( = 0.002). Intriguingly, levels of serum AAT do not correlate with levels of C-reactive protein, neutrophils-to-leukocyte ratio, and do not correlate with expression or AAT staining in the tumor tissue. Additional experiments revealed that external AAT and/or overexpressed gene significantly improve cancer cell migration, colony formation and resistance to apoptosis. gene and AAT protein play an active role in the pathogenesis of lung cancer and not just reflect inflammatory reaction related to cancer development.

摘要

编码急性期蛋白α1-抗胰蛋白酶(AAT)的基因高表达与多种肿瘤相关。我们试图研究[基因名称]和AAT蛋白在非小细胞肺癌(NSCLC)患者及NSCLC细胞系中的意义。对351例NSCLC患者的肿瘤及邻近非肿瘤肺组织和血清样本进行了[基因名称]表达及AAT蛋白水平分析。我们还研究了[基因名称]表达和AAT蛋白对H1975和H661细胞行为的影响。肿瘤组织中[基因名称]表达较低而邻近非肿瘤肺组织中较高(n = 351,P = 0.016),以及血清中AAT蛋白水平较高(n = 170,P = 0.033)均与较差的生存率相关。具体而言,在NSCLC III期患者中,较高的血液AAT水平(>2.66 mg/mL)与较差的生存率相关(P = 0.002)。有趣的是,血清AAT水平与C反应蛋白水平、中性粒细胞与白细胞比值均无相关性,且与肿瘤组织中的[基因名称]表达或AAT染色也无相关性。进一步实验表明,外源性AAT和/或过表达的[基因名称]显著促进癌细胞迁移、集落形成及抗凋亡能力。[基因名称]和AAT蛋白在肺癌发病机制中发挥积极作用,而不仅仅反映与癌症发展相关的炎症反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db7a/6770941/677312a44b89/cancers-11-01306-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db7a/6770941/dc7b325c80fa/cancers-11-01306-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db7a/6770941/682741423d48/cancers-11-01306-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db7a/6770941/a626869393b2/cancers-11-01306-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db7a/6770941/bd0f7549cfaa/cancers-11-01306-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db7a/6770941/66e777acad2e/cancers-11-01306-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db7a/6770941/86f1bd133fdd/cancers-11-01306-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db7a/6770941/677312a44b89/cancers-11-01306-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db7a/6770941/dc7b325c80fa/cancers-11-01306-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db7a/6770941/682741423d48/cancers-11-01306-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db7a/6770941/a626869393b2/cancers-11-01306-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db7a/6770941/bd0f7549cfaa/cancers-11-01306-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db7a/6770941/66e777acad2e/cancers-11-01306-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db7a/6770941/86f1bd133fdd/cancers-11-01306-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db7a/6770941/677312a44b89/cancers-11-01306-g007.jpg

相似文献

1
Clinical Significance of Gene and Its Encoded Alpha1-antitrypsin Protein in NSCLC.基因及其编码的α1-抗胰蛋白酶蛋白在非小细胞肺癌中的临床意义
Cancers (Basel). 2019 Sep 4;11(9):1306. doi: 10.3390/cancers11091306.
2
SERPINA1 long transcripts produce non-secretory alpha1-antitrypsin isoform: In vitro translation in living cells.丝氨酸蛋白酶抑制剂 A1 基因长转录本产生无分泌型α1-抗胰蛋白酶同工型:活细胞内的体外翻译。
Int J Biol Macromol. 2023 Jun 30;241:124433. doi: 10.1016/j.ijbiomac.2023.124433. Epub 2023 Apr 21.
3
Alpha1-antitrypsin protects lung cancer cells from staurosporine-induced apoptosis: the role of bacterial lipopolysaccharide.α1-抗胰蛋白酶通过脂多糖保护肺癌细胞免受星形孢菌素诱导的凋亡
Sci Rep. 2020 Jun 12;10(1):9563. doi: 10.1038/s41598-020-66825-w.
4
Towards unveiling the nature of short SERPINA1 transcripts: Avoiding the main ORF control to translate alpha1-antitrypsin C-terminal peptides.揭示短SERPINA1转录本的本质:避开主要开放阅读框控制以翻译α1-抗胰蛋白酶C末端肽段。
Int J Biol Macromol. 2022 Apr 1;203:703-717. doi: 10.1016/j.ijbiomac.2022.01.131. Epub 2022 Jan 26.
5
Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency.α-1抗胰蛋白酶缺乏症中SERPINA1基因的可变转录本
J Transl Med. 2015 Jul 4;13:211. doi: 10.1186/s12967-015-0585-y.
6
Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinoma.跨膜丝氨酸蛋白酶 2 是肺腺癌的一个预后因素。
Int J Oncol. 2022 Apr;60(4). doi: 10.3892/ijo.2022.5329. Epub 2022 Feb 25.
7
SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency.丝氨酸蛋白酶抑制剂A1(SERPINA1)信使核糖核酸作为α-1抗胰蛋白酶缺乏症的一种治疗方法。
J Nucleic Acids. 2018 Jun 13;2018:8247935. doi: 10.1155/2018/8247935. eCollection 2018.
8
Alpha-1 antitrypsin expression is upregulated in multidrug-resistant cancer cells.α-1 抗胰蛋白酶在多药耐药癌细胞中表达上调。
Histochem Cell Biol. 2023 May;159(5):431-437. doi: 10.1007/s00418-022-02172-3. Epub 2022 Dec 19.
9
Characterization of Novel Missense Variants of SERPINA1 Gene Causing Alpha-1 Antitrypsin Deficiency.鉴定导致α-1 抗胰蛋白酶缺乏症的 SERPINA1 基因突变的新型错义变异。
Am J Respir Cell Mol Biol. 2018 Jun;58(6):706-716. doi: 10.1165/rcmb.2017-0179OC.
10
Identification and characterisation of eight novel SERPINA1 Null mutations.八个新型丝氨酸蛋白酶抑制剂A1(SERPINA1)无效突变的鉴定与特征分析
Orphanet J Rare Dis. 2014 Nov 26;9:172. doi: 10.1186/s13023-014-0172-y.

引用本文的文献

1
A multi-cohort validated OXPHOS signature predicts survival and immune profiles in grade II/III glioma patients.一种经过多队列验证的氧化磷酸化特征可预测II/III级胶质瘤患者的生存率和免疫特征。
Front Immunol. 2025 Aug 1;16:1638824. doi: 10.3389/fimmu.2025.1638824. eCollection 2025.
2
GPER1 is involved in shaping tumor immune microenvironment and its expression is decreased in NSCLC tumorigenesis.G蛋白偶联雌激素受体1(GPER1)参与塑造肿瘤免疫微环境,且其表达在非小细胞肺癌发生过程中降低。
Sci Rep. 2025 Aug 12;15(1):29488. doi: 10.1038/s41598-025-15405-x.
3
Serum levels of C-terminal peptides of alpha-1 antitrypsin as potential biomarkers in non-small cell lung cancer.

本文引用的文献

1
Proteomics analysis of human serum of patients with non-small-cell lung cancer reveals proteins as diagnostic biomarker candidates.非小细胞肺癌患者血清蛋白质组学分析揭示了作为诊断生物标志物候选物的蛋白质。
J Cell Physiol. 2019 Dec;234(12):23798-23806. doi: 10.1002/jcp.28948. Epub 2019 Jun 10.
2
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC.FAM83A和FAM83B作为非小细胞肺癌的预后生物标志物及潜在的新治疗靶点
Cancers (Basel). 2019 May 11;11(5):652. doi: 10.3390/cancers11050652.
3
Protein expression profiling of plasma and lungs at different stages of metastatic development in a human triple negative breast cancer xenograft model.
α-1抗胰蛋白酶C末端肽的血清水平作为非小细胞肺癌的潜在生物标志物
Transl Lung Cancer Res. 2025 Jun 30;14(6):2113-2124. doi: 10.21037/tlcr-2025-178. Epub 2025 Jun 23.
4
A Pilot Study: Contrasting Genomic Profiles of Lung Adenocarcinoma Between Patients of European and Latin American Ancestry.一项初步研究:对比欧洲和拉丁美洲裔患者肺腺癌的基因组图谱。
Int J Mol Sci. 2025 May 19;26(10):4865. doi: 10.3390/ijms26104865.
5
Decoding resistance to immune checkpoint inhibitors in non-small cell lung cancer: a comprehensive analysis of plasma proteomics and therapeutic implications.非小细胞肺癌中免疫检查点抑制剂耐药性的解码:血浆蛋白质组学综合分析及治疗意义
J Immunother Cancer. 2025 May 22;13(5):e011427. doi: 10.1136/jitc-2024-011427.
6
Bioinformatic analysis of serpina1 expression in papillary thyroid carcinoma and its potential association with Hashimoto's thyroiditis.甲状腺乳头状癌中丝氨酸蛋白酶抑制剂A1(Serpina1)表达的生物信息学分析及其与桥本甲状腺炎的潜在关联。
Discov Oncol. 2025 Mar 19;16(1):356. doi: 10.1007/s12672-025-02079-0.
7
Exploring Core Genes Associated with Sepsis and Systemic Inflammatory Response Syndrome Using Single-Cell Sequencing Technology.使用单细胞测序技术探索与脓毒症和全身炎症反应综合征相关的核心基因。
J Inflamm Res. 2025 Feb 6;18:1815-1838. doi: 10.2147/JIR.S448900. eCollection 2025.
8
Serum α1-AT Levels and Molecular Analysis in Breast Cancer: An Experimental and Computational Study.乳腺癌患者血清α1-抗胰蛋白酶水平及分子分析:一项实验与计算研究
Diseases. 2024 Dec 24;13(1):1. doi: 10.3390/diseases13010001.
9
Whole-genome analysis of plasma fibrinogen reveals population-differentiated genetic regulators with putative liver roles.全基因组分析血浆纤维蛋白原揭示了具有潜在肝脏作用的人群分化的遗传调控因子。
Blood. 2024 Nov 21;144(21):2248-2265. doi: 10.1182/blood.2023022596.
10
CEBPB-mediated upregulation of SERPINA1 promotes colorectal cancer progression by enhancing STAT3 signaling.CEBPB介导的SERPINA1上调通过增强STAT3信号传导促进结直肠癌进展。
Cell Death Discov. 2024 May 6;10(1):219. doi: 10.1038/s41420-024-01990-9.
在人三阴性乳腺癌异种移植模型中转移发展的不同阶段血浆和肺组织的蛋白表达谱分析。
PLoS One. 2019 May 1;14(5):e0215909. doi: 10.1371/journal.pone.0215909. eCollection 2019.
4
Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival.乳腺癌的整合蛋白质组学转录组学研究揭示了与亚型和生存相关的全局蛋白质-mRNA 一致性增加。
Genome Med. 2018 Dec 3;10(1):94. doi: 10.1186/s13073-018-0602-x.
5
PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools.PANTHER 版本 14:更多基因组、一个新的 PANTHER GO-slim 和富集分析工具的改进。
Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426. doi: 10.1093/nar/gky1038.
6
Silence of α1-Antitrypsin Inhibits Migration and Proliferation of Triple Negative Breast Cancer Cells.α1-抗胰蛋白酶沉默抑制三阴性乳腺癌细胞的迁移和增殖。
Med Sci Monit. 2018 Sep 27;24:6851-6860. doi: 10.12659/MSM.910665.
7
Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis.癌细胞对缺氧的适应涉及 HIF-GPRC5A-YAP 轴。
EMBO Mol Med. 2018 Nov;10(11). doi: 10.15252/emmm.201708699.
8
The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions.α1-抗胰蛋白酶对中性粒细胞功能的多方面影响。
Front Pharmacol. 2018 Apr 17;9:341. doi: 10.3389/fphar.2018.00341. eCollection 2018.
9
Understanding the tumor immune microenvironment (TIME) for effective therapy.理解肿瘤免疫微环境(TIME)以实现有效的治疗。
Nat Med. 2018 May;24(5):541-550. doi: 10.1038/s41591-018-0014-x. Epub 2018 Apr 23.
10
Combination of platelet count and lymphocyte to monocyte ratio is a prognostic factor in patients undergoing surgery for non-small cell lung cancer.血小板计数与淋巴细胞单核细胞比值的联合是接受非小细胞肺癌手术患者的一个预后因素。
Oncotarget. 2017 Jun 1;8(42):73198-73207. doi: 10.18632/oncotarget.18336. eCollection 2017 Sep 22.